198 related articles for article (PubMed ID: 30017829)
1. Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma.
Sharpnack MF; Ranbaduge N; Srivastava A; Cerciello F; Codreanu SG; Liebler DC; Mascaux C; Miles WO; Morris R; McDermott JE; Sharpnack JL; Amann J; Maher CA; Machiraju R; Wysocki VH; Govindan R; Mallick P; Coombes KR; Huang K; Carbone DP
J Thorac Oncol; 2018 Oct; 13(10):1519-1529. PubMed ID: 30017829
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
Zhang Y; Fu F; Zhang Q; Li L; Liu H; Deng C; Xue Q; Zhao Y; Sun W; Han H; Gao Z; Guo C; Zheng Q; Hu H; Sun Y; Li Y; Ding C; Chen H
Cell Rep Med; 2024 Jan; 5(1):101358. PubMed ID: 38183982
[TBL] [Abstract][Full Text] [Related]
3. Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.
Ha ES; Choi S; In KH; Lee SH; Lee EJ; Lee SY; Kim JH; Shin C; Shim JJ; Kang KH; Phark S; Sul D
Clin Biochem; 2013 Mar; 46(4-5):369-77. PubMed ID: 23200884
[TBL] [Abstract][Full Text] [Related]
4. Prediction of distant recurrence in resected stage I and II lung adenocarcinoma.
Aramini B; Casali C; Stefani A; Bettelli S; Wagner S; Sangale Z; Hughes E; Lanchbury JS; Maiorana A; Morandi U
Lung Cancer; 2016 Nov; 101():82-87. PubMed ID: 27794412
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular signatures associated with early relapse after complete resection of lung adenocarcinomas.
Pasternack H; Kuempers C; Deng M; Watermann I; Olchers T; Kuehnel M; Jonigk D; Kugler C; Stellmacher F; Goldmann T; Kirfel J; Ammerpohl O; Perner S; Reck M
Sci Rep; 2021 May; 11(1):9532. PubMed ID: 33953302
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma.
Takamochi K; Oh S; Matsunaga T; Suzuki K
J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1768-1774.e1. PubMed ID: 28826599
[TBL] [Abstract][Full Text] [Related]
8. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
Am J Surg Pathol; 2019 Aug; 43(8):1033-1041. PubMed ID: 31107717
[TBL] [Abstract][Full Text] [Related]
9. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension.
Lin MW; Wu CT; Shih JY; Chang YL; Yang PC
J Surg Oncol; 2014 Aug; 110(2):99-106. PubMed ID: 24788590
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
13. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
[TBL] [Abstract][Full Text] [Related]
15. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
Heon S; Johnson BE
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
[TBL] [Abstract][Full Text] [Related]
17. EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.
Fan CC; Cheng WC; Huang YC; Sher YP; Liou NJ; Chien YC; Lin PS; Lin PS; Chen CH; Chang WC
Sci Rep; 2017 Nov; 7(1):14617. PubMed ID: 29097801
[TBL] [Abstract][Full Text] [Related]
18. The role of the ground-glass opacity ratio in resected lung adenocarcinoma.
Huang TW; Lin KH; Huang HK; Chen YI; Ko KH; Chang CK; Hsu HH; Chang H; Lee SC
Eur J Cardiothorac Surg; 2018 Aug; 54(2):229-234. PubMed ID: 29471517
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
20. A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis.
Nishimura T; Nakamura H; Tan KT; Zhuo DW; Fujii K; Koizumi H; Naruki S; Takagi M; Furuya N; Kato Y; Chen SJ; Kato H; Saji H
Sci Rep; 2020 Aug; 10(1):13604. PubMed ID: 32788598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
